Published :
Tables : 48
Figures : 43
Category : Healthcare
No. of Pages : 225
Report Code : HC-1149
Veterinary Infectious Disease Diagnostics Market Overview: The growing population of companion animal population coupled with the increasing demand of latest veterinary infectious disease diagnostic equipment is driving the market growth. The growing need for pet insurance alongside increasing disease control and prevention guidelines is stimulating the market. In addition, the increasing cases of food and zoonotic and foodborne diseases is leading to more efficient diagnostic options, thus propelling the market. The market is bifurcated into technology, animal type, end-user, and by region. In terms of technology, immunodiagnostics segment dominantes the market. Increasing demand for early disease detection and diagnosis coupled with improvements in the immunoassay formats is propelling the market. Based on animal type, the companion animals are expected to dictate the market growth. Growing disease control and disease prevention and rise in the adoption of dogs and cats are driving the growth of the companion animal segment. Rising penetration of pet insurance alongside the growing number of veterinary practitioners globally is fueling the demand of the market. Based on sub segment infections type, viral infections, the growing need to prevent infections from animal to humans and animals to animals is driving the market growth. The growing need to detect diseases in animals is also driving the market growth. Based on end-users, reference laboratories are expected to dominate the growth of the market. The rise in the number of samples for analysis coupled with rise in in-house testing is bolstering the market. In terms of regions, North America accounts for a vast share of the market. Growing animal healthcare expenditure and prevalence of multiple animal diseases and injuries is bolstering the market in the region. Additionally, rising pet adoption is positively influencing the market. Asia-Pacific region is expected to showcase exponential growth. Emerging economies like China, India, and South Korea are offering lucrative opportunities for manufacturers and key players. Rising incidences of zoonotic diseases and growing demand for infectious disease diagnostics is driving the market growth in the region. Major players included in the Veterinary Infectious Disease Diagnostics Market: • Biomerieux S.A. • Heska Corporation • Idexx Laboratories, Inc. • IDVet • Neogen Corporation • Qiagen N.V. (A Part Of Indical Bioscience) • Randox Laboratories, Ltd. • Thermo Fisher Scientific • Virbac • Zoetis, Inc. • Abbott Laboratories • Creative Diagnostics • Innovative Diagnostics. (Note: The list of the major players will be updated with the latest market scenario and trends) Veterinary Infectious Disease Diagnostics Market Segmentation: By Technology • Immunodiagnostics o Lateral Flow Assays o Elisa Tests o Other Immunodiagnostic Products • Molecular Diagnostics o Polymerase Chain Reaction (PCR) Tests o Microarrays o Other Molecular Diagnostic Products • Other Technologies By Animal Type • Companion Animals o By Animal Type o Dogs o Cats o Horses o Other Companion Animals o By Infection Type o Viral Infections o Bacterial Infections o Parasitic Infections o Other Infections • Food-Producing Animals o By Animal Type o Cattle o Swine o Poultry o Other Food-Producing Animals o By Infection Type o Bacterial Infections o Viral Infections o Parasitic Infections o Other Infections By End User • Reference Laboratories • Veterinary Hospitals & Clinics • Point-Of-Care/In-House Testing • Research Institutes & Universities By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Veterinary Infectious Disease Diagnostics Market By Technology, By Animal Type, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The growing population of companion animal population coupled with the increasing demand of latest veterinary infectious disease diagnostic equipment is driving the market growth. The growing need for pet insurance alongside increasing disease control and prevention guidelines is stimulating the market. In addition, the increasing cases of food and zoonotic and foodborne diseases is leading to more efficient diagnostic options, thus propelling the market.
The market is bifurcated into technology, animal type, end-user, and by region. In terms of technology, immunodiagnostics segment dominantes the market. Increasing demand for early disease detection and diagnosis coupled with improvements in the immunoassay formats is propelling the market.
Based on animal type, the companion animals are expected to dictate the market growth. Growing disease control and disease prevention and rise in the adoption of dogs and cats are driving the growth of the companion animal segment. Rising penetration of pet insurance alongside the growing number of veterinary practitioners globally is fueling the demand of the market.
Based on sub segment infections type, viral infections, the growing need to prevent infections from animal to humans and animals to animals is driving the market growth. The growing need to detect diseases in animals is also driving the market growth.
Based on end-users, reference laboratories are expected to dominate the growth of the market. The rise in the number of samples for analysis coupled with rise in in-house testing is bolstering the market.
In terms of regions, North America accounts for a vast share of the market. Growing animal healthcare expenditure and prevalence of multiple animal diseases and injuries is bolstering the market in the region. Additionally, rising pet adoption is positively influencing the market.
Asia-Pacific region is expected to showcase exponential growth. Emerging economies like China, India, and South Korea are offering lucrative opportunities for manufacturers and key players. Rising incidences of zoonotic diseases and growing demand for infectious disease diagnostics is driving the market growth in the region.
Major players included in the Veterinary Infectious Disease Diagnostics Market: • Biomerieux S.A. • Heska Corporation • Idexx Laboratories, Inc. • IDVet • Neogen Corporation • Qiagen N.V. (A Part Of Indical Bioscience) • Randox Laboratories, Ltd. • Thermo Fisher Scientific • Virbac • Zoetis, Inc. • Abbott Laboratories • Creative Diagnostics • Innovative Diagnostics. (Note: The list of the major players will be updated with the latest market scenario and trends)
Veterinary Infectious Disease Diagnostics Market Segmentation:
By Technology • Immunodiagnostics o Lateral Flow Assays o Elisa Tests o Other Immunodiagnostic Products • Molecular Diagnostics o Polymerase Chain Reaction (PCR) Tests o Microarrays o Other Molecular Diagnostic Products • Other Technologies
By Animal Type • Companion Animals o By Animal Type o Dogs o Cats o Horses o Other Companion Animals o By Infection Type o Viral Infections o Bacterial Infections o Parasitic Infections o Other Infections • Food-Producing Animals o By Animal Type o Cattle o Swine o Poultry o Other Food-Producing Animals o By Infection Type o Bacterial Infections o Viral Infections o Parasitic Infections o Other Infections
By End User • Reference Laboratories • Veterinary Hospitals & Clinics • Point-Of-Care/In-House Testing • Research Institutes & Universities
By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Veterinary Infectious Disease Diagnostics Market By Technology, By Animal Type, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Veterinary Infectious Disease Diagnostics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Veterinary Infectious Disease Diagnostics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Veterinary Infectious Disease Diagnostics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Veterinary Infectious Disease Diagnostics Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Immunodiagnostics 7.1.1. Lateral Flow Assays 7.1.2. Elisa Tests 7.1.3. Other Immunodiagnostic Products 7.2. Molecular Diagnostics 7.2.1. Polymerase Chain Reaction (PCR) Tests 7.2.2. Microarrays 7.2.3. Other Molecular Diagnostic Products 7.3. Other Technologies 8. Global Veterinary Infectious Disease Diagnostics Market, By Animal Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Companion Animals 8.1.1. By Animal Type 8.1.1.1. Dogs 8.1.1.2. Cats 8.1.1.3. Horses 8.1.1.4. Other Companion Animals 8.1.2. By Infection Type 8.1.2.1. Viral Infections 8.1.2.2. Bacterial Infections 8.1.2.3. Parasitic Infections 8.1.2.4. Other Infections 8.2. Food-Producing Animals 8.2.1. By Animal Type 8.2.1.1. Cattle 8.2.1.2. Swine 8.2.1.3. Poultry 8.2.1.4. Other Food-Producing Animals 8.2.2. By Infection Type 8.2.2.1. Bacterial Infections 8.2.2.2. Viral Infections 8.2.2.3. Parasitic Infections 8.2.2.4. Other Infections 9. Global Veterinary Infectious Disease Diagnostics Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Reference Laboratories 9.2. Veterinary Hospitals & Clinics 9.3. Point-Of-Care/In-House Testing 9.4. Research Institutes & Universities 10. North America Veterinary Infectious Disease Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Veterinary Infectious Disease Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Veterinary Infectious Disease Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Veterinary Infectious Disease Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Veterinary Infectious Disease Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Biomerieux S.A. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Heska Corporation 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Idexx Laboratories, Inc. 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. IDVet 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Neogen Corporation 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Qiagen N.V. (A Part Of Indical Bioscience) 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Randox Laboratories, Ltd. 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Thermo Fisher Scientific 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Virbac 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Zoetis, Inc. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Abbott Laboratories 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Creative Diagnostics 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Innovative Diagnosticsc. 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Veterinary Infectious Disease Diagnostics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Veterinary Infectious Disease Diagnostics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Veterinary Infectious Disease Diagnostics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Veterinary Infectious Disease Diagnostics Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Immunodiagnostics 7.1.1. Lateral Flow Assays 7.1.2. Elisa Tests 7.1.3. Other Immunodiagnostic Products 7.2. Molecular Diagnostics 7.2.1. Polymerase Chain Reaction (PCR) Tests 7.2.2. Microarrays 7.2.3. Other Molecular Diagnostic Products 7.3. Other Technologies
8. Global Veterinary Infectious Disease Diagnostics Market, By Animal Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Companion Animals 8.1.1. By Animal Type 8.1.1.1. Dogs 8.1.1.2. Cats 8.1.1.3. Horses 8.1.1.4. Other Companion Animals 8.1.2. By Infection Type 8.1.2.1. Viral Infections 8.1.2.2. Bacterial Infections 8.1.2.3. Parasitic Infections 8.1.2.4. Other Infections 8.2. Food-Producing Animals 8.2.1. By Animal Type 8.2.1.1. Cattle 8.2.1.2. Swine 8.2.1.3. Poultry 8.2.1.4. Other Food-Producing Animals 8.2.2. By Infection Type 8.2.2.1. Bacterial Infections 8.2.2.2. Viral Infections 8.2.2.3. Parasitic Infections 8.2.2.4. Other Infections
9. Global Veterinary Infectious Disease Diagnostics Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Reference Laboratories 9.2. Veterinary Hospitals & Clinics 9.3. Point-Of-Care/In-House Testing 9.4. Research Institutes & Universities
10. North America Veterinary Infectious Disease Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Veterinary Infectious Disease Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Veterinary Infectious Disease Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Veterinary Infectious Disease Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Veterinary Infectious Disease Diagnostics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. Biomerieux S.A. 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Heska Corporation 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Idexx Laboratories, Inc. 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. IDVet 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Neogen Corporation 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Qiagen N.V. (A Part Of Indical Bioscience) 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Randox Laboratories, Ltd. 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Thermo Fisher Scientific 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Virbac 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Zoetis, Inc. 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Abbott Laboratories 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Creative Diagnostics 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Innovative Diagnosticsc. 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics